In contrast, treatment with recombinant IL-33 (rIL-33) exacerbated the AKI with an increase in CD4 T-cell infiltration, serum creatinine, ATN, and apoptosis (17). This evidence concerns the gene CD4 and oculocutaneous albinism type 1.